Zusammenfassung
Die Tumoren entstehen durch Proliferation von Anteilen fetalen Chorions, der Differenzierungsgrad spannt sich von benigne bis hoch maligne. GTE sind durch eine ausgeprägte Chemosensitivität gekennzeichnet und gelten — zusammen mit den Hodentumoren und den akuten Leuk?mien — als die malignen Erkrankungen, die durch Chemotherapie heilbar sind.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Azab M, Droz JP, Theodore C et al. (1989) Cisplatin, Vinblastine, and Bleomycin combination in the Treatment of Resistant High-Risk Gestational Trophoblastic Tumors. Cancer 64: 1829–1818
Bae SN, Kim SJ (1999) Telomerase activity in complete hydatidiform mole. Am J Obstet Gyneco1180 (2): 328–333
Bagshawe KD (1992) Trophoblastic tumors: Diagnostic Methods, Epidemiology, Clinical Features and Management. In: Coppleson M (ed) Gynecologic Oncology. Edinburgh, London, Melbourne, New York, Tokyo: Churchill Livingstone: 1027–1043
Bagshawe KD, Dent J, Newlands ES, Begent RHJ, Bustin GJS (1989) The Role of Low-Dose Methotrexate and Folinic Acid in Gestational Trophoblastic Tumours ( GTT ). Br J Obstet Gynecol 96: 795–802
Cheung AN, Shen DH, Khoo US et al. (1998) p21WAF/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and pS3 gene expression. J Clin Pathol 51 (2): 159–162
Chilosi M, Piazzola E, Lestani M et al. (1998) Differential expression of pS7k’P2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest 78 (3): 269–276
Fulop V, Mok SC, Genest DR et al. (1998) p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med 43 (2): 119–127
Jauniaux E (1999) Partial moles: from postnatal to prenatal diagnosis. Placenta 20 (5–6): 379–388
Matsui H, Iitsuka Y, Seki K et al. (1998) Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities. Gynecol Obstet Invest 46 (1): 5–8
Molykutty J, Rajalekshmy TN, Balaraman NM et al. (1998) Proliferating cell nuclear antigen (PCNA) expression in gestational trophoblastic disease (GTD). Neoplasma 45 (5): 301–304
Newlands ES, Bagshawe KD, Begent RHJ et al. (1986) Developments in Chemotherapy for Medium- and High-Risk Patients with Gestational Trophoblastic Tumours (1979–1984). Br J Obstet Gynecol 93: 63–69
Newlands ES, Bower M, Holden L et al. (1998) Management of resistant gestational trophoblastic tumors. J Reprod Med 43 (2): iii-118
Palmer JR, Drscoll SG, Rosenberg L et al. (1999) Oral contraceptive use and risk of gestational trophoblastic tumors. J Natl Cancer Inst 91 (7): 635–64o
Smith EB, Weed JC, Tyrey L, Hammond CB (1982) Treatment of Nonmetastatic Gestational Trophoblastic Disease: Results of Methotrexate Alone versus Methotrexate-Folinic Acid. Am J Obstet Gynecol 144: 88–92
Soper JT, Evans AC, Clarke-Pearson DL et al (1994) Alternating weekly chemotherapy with Etoposide-Methotrexate-Dactinomycin/Cyclophosphamide-Vincristine for high-risk gestational trophoblastic disease. Obstet Gynecol 83 (1): 113–117
Theodore C, Azab M, Droz JP et al. (1989) Treatment of High-Risk Gestational Trophoblastic Disease With Chemotherapy Combinations Containing Cisplatin and Etoposide. Cancer 64: 1824–1828
Wong LC, Choo YC, Ma HK (1985) Methotrexate with Citrovorum Factor Rescue in Gestational Trophoblastic Disease. Am J Obstet Gynecol 152: 59–62
Woolas RP, Bower M,Newlands ES et al. (1998) Influence of chemotherapy for gestational trophoblastic disease on pregnancy outcome. Br J Obstet Gynecol 105 (9): 1032–1035
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Costa, S.D. (2003). Gestationsbedingte Trophoblasterkrankungen (Blasenmole und Chorionkarzinom). In: Kaufmann, M., Costa, S.D., Scharl, A. (eds) Die Gynäkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-11496-4_26
Download citation
DOI: https://doi.org/10.1007/978-3-662-11496-4_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-11497-1
Online ISBN: 978-3-662-11496-4
eBook Packages: Springer Book Archive